TABLE 2.
PTP levels of PM-implanted CVID PBMCs stimulated with anti-human IgM antibodya
| Patient | Densitometry unitsb
|
|||||
|---|---|---|---|---|---|---|
| P
|
N
|
P/N ratio
|
||||
| − | + | − | + | − | + | |
| P1 | 135,022 | 287,881 | 242,735 | 241,848 | 0.55 | 1.19 |
| P2 | 488,997 | 731,477 | 683,251 | 760,964 | 0.71 | 0.96 |
| P5 | 942,027 | 1,210,743 | 1,290,228 | 1,178,417 | 0.73 | 1.02 |
| P12 | 768,333 | 1,186,863 | 1,290,228 | 1,178,417 | 0.59 | 1.00 |
| P13 | 433,695 | 718,495 | 683,251 | 760,964 | 0.63 | 0.94 |
See Table 1, footnote a.
Results are given as determined with (+) or without (−) PM implantation.